A M Cabibbe
Overview
Explore the profile of A M Cabibbe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
135
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bouzouita I, Cabibbe A, Ghariani A, Smaoui S, Draoui H, Bejaoui S, et al.
Int J Tuberc Lung Dis
. 2025 Feb;
29(2):92-94.
PMID: 39891337
No abstract available.
2.
Saderi L, Cabibbe A, Puci M, Di Lorenzo B, Centis R, Pontali E, et al.
Int J Tuberc Lung Dis
. 2023 May;
27(5):348-356.
PMID: 37143228
We performed an analysis of the cost and relative merits of different strategies for the diagnosis of multidrug-resistant/extensively drug-resistant TB (MDR/XDR-TB) in different settings. We systematically reviewed the published evidence...
3.
Akkerman O, Duarte R, Tiberi S, Schaaf H, Lange C, Alffenaar J, et al.
Int J Tuberc Lung Dis
. 2022 Jun;
26(7):592-604.
PMID: 35768923
The aim of these clinical standards is to provide guidance on 'best practice´ for diagnosis, treatment and management of drug-susceptible pulmonary TB (PTB). A panel of 54 global experts in...
4.
Mesfin A, Araia Z, Beyene H, Mebrahtu A, Suud N, Berhane Y, et al.
Int J Tuberc Lung Dis
. 2021 Jan;
25(1):43-51.
PMID: 33384044
In the absence of reliable data on drug-resistant TB in Eritrea, a national survey was conducted in 2018 using molecular-based methods, bypassing the need for culture. A cross-sectional study was...
5.
Battaglia S, Spitaleri A, Cabibbe A, Meehan C, Utpatel C, Ismail N, et al.
J Clin Microbiol
. 2020 Sep;
58(11).
PMID: 32907992
The role of mutations in genes associated with phenotypic resistance to bedaquiline (BDQ) and delamanid (DLM) in complex (MTBc) strains is poorly characterized. A clear understanding of the genetic variants'...
6.
Rigouts L, Miotto P, Schats M, Lempens P, Cabibbe A, Galbiati S, et al.
Sci Rep
. 2019 Aug;
9(1):11760.
PMID: 31409849
Heteroresistance - the simultaneous presence of drug-susceptible and -resistant organisms - is common in Mycobacterium tuberculosis. In this study, we aimed to determine the limit of detection (LOD) of genotypic...
7.
Bouzouita I, Cabibbe A, Trovato A, Draoui H, Ghariani A, Midouni B, et al.
Int J Tuberc Lung Dis
. 2018 Jun;
22(6):661-666.
PMID: 29862951
Setting: Phenotypic tests used to detect pyrazinamide (PZA) resistance are slow and have a high rate of false resistance. Objective: To evaluate the accuracy of pncA sequencing for the detection...
8.
Pavlenko E, Barbova A, Hovhannesyan A, Tsenilova Z, Slavuckij A, Shcherbak-Verlan B, et al.
Int J Tuberc Lung Dis
. 2018 Mar;
22(2):197-205.
PMID: 29506617
Setting: The true prevalence of multidrug-resistant tuberculosis (MDR-TB) in Ukraine is not known. Available data are a decade old and limited to only one province. Objective: To determine the prevalence...
9.
Driesen M, Kondo Y, de Jong B, Torrea G, Asnong S, Desmaretz C, et al.
Clin Microbiol Infect
. 2017 Jun;
24(1):60-64.
PMID: 28587904
Objectives: The development of rapid molecular diagnostic assays for pyrazinamide (PZA) resistance is considered technically challenging as mutations are highly diverse, scattered along the full length of the pncA gene...
10.
Cabibbe A, Cirillo D
Int J Mycobacteriol
. 2017 Jan;
5 Suppl 1:S40-S41.
PMID: 28043601
In 2014, the World Health Organization (WHO) recommendation to include the endorsed rapid molecular technologies (Xpert MTB/RIF, line probe assays) into surveillance systems and surveys allowed the testing of more...